Pharmac has decided to disestablish it's Māori advisory group. In a statement, the chairperson of the drug funding agency ...

Pharmac is set to fund an at-home testing kit to find out if a pregnancy termination has been successful. The testing kit ...

Pharmac only established Te Rōpū in 2021 after a damning independent review of the agency and health outcomes for Māori, ...

Pharmac is funding Lisdexamfetamine for ADHD and narcolepsy, benefiting more than 6000 people from December. Pharmac is ...

From 1 December 2024, Pharmac is also removing the renewal criteria for methylphenidate, dexamfetamine and modafinil, medicines used to treat ADHD and narcolepsy. This means that once an initial ...

Pharmac has decided to fund an at-home low sensitivity test kit that confirms a pregnancy has ended following a medical abortion. The urine test kit (branded as CheckToP) detects the levels of ...

Advocacy group Aroreretini Aotearoa, says the changes will improve productivity for the ADHD community, by almost 57-million-dollars. Chief medical officer David Hughes says it will streamline ...

Watch these hacks and boost your cooking skills cooking hacks Hīkoi to Parliament: David Seymour warns parents who take their ...

Go ahead and explore some trendy long hairdos hack ideas ...

Pharmac has decided to fund lenvatinib from 1 December 2024 for people with some types of thyroid, liver, and kidney cancer. Lenvatinib (branded as Lenvima) stops the number of cancer cells from ...

More collaborative initiatives are taking place among regulatory agencies, health technology assessment (HTA) bodies and ...

Pharmac has announced it'll fund new stimulant medicine lisdexamfetamine from December. The medicine -- branded as Vyvanse -- is taken once a day. Chief medical officer, David Hughes, says it's a ...